Alkermes PLC (ALKS) Shares Fall 3.2% -- GF Value Says Still Overvalued

gurufocus.com · 2026-09-24

On September 24, 2026, Alkermes PLC (ALKS) shares fell 3.2%, closing at $40.79. This decline is part of a larger trend, with the stock down 12.7% over the past

TickrTrends take: Alkermes shares declined following negative valuation commentary, yet the stock remains classified as overvalued according to GF Value metrics, consistent with TickrTrends' current assessment of the Healthcare sector company. For investors focused on valuation fundamentals, the recent price weakness does not appear to have closed the gap between current market pricing and intrinsic value estimates. Continued monitoring of the company's financial performance and valuation multiples will be important to determine whether further price adjustments occur or if the overvalued status persists.

Read the full story at gurufocus.com →